These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
35. National randomized study of chemotherapeutic agents in advanced prostatic carcinoma: a progress report. Johnson DE, Scott WW, Gibbons RP, Prout GR, Schmidt JD, Chu TM, Gaeta J, Saroff J, Murphy GP. Cancer Treat Rep; 1977 Nov 10; 61(2):317-23. PubMed ID: 141326 [Abstract] [Full Text] [Related]
38. A comparison of the effect of diethylstilbestrol with low dose estramustine phosphate in the treatment of advanced prostatic cancer: final analysis of a phase III trial of the European Organization for Research on Treatment of Cancer. Smith PH, Suciu S, Robinson MR, Richards B, Bastable JR, Glashan RW, Bouffioux C, Lardennois B, Williams RE, de Pauw M. J Urol; 1986 Sep 10; 136(3):619-23. PubMed ID: 3525866 [Abstract] [Full Text] [Related]
39. Continuous versus intermittent oral therapy with estramustine phosphate (Estracyt). Vahlensieck W, Wegner G. Scand J Urol Nephrol Suppl; 1980 Sep 10; 55():147-9. PubMed ID: 6938018 [Abstract] [Full Text] [Related]
40. Cooperative clinical trials of the National Prostatic Cancer Project: Protocol 900. Schmidt JD. Prostate; 1984 Sep 10; 5(4):387-99. PubMed ID: 6377283 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]